Literature DB >> 3943482

The physiological role of relaxin in the pregnant rat. IV. The influence of relaxin on cervical collagen and glycosaminoglycans.

S J Downing, O D Sherwood.   

Abstract

Changes in the collagen and glycosaminoglycan components of cervical connective tissue were studied in nonpregnant, intact pregnant, and ovariectomized hormone-treated pregnant rats. Collagen concentration and solubility and the concentration of the glycosaminoglycans dermatan sulfate (DS), heparan sulfate, and hyaluronic acid (HA) in cervices taken from day 9 (D9) pregnant rats were similar to those in cervices from nonpregnant rats. In cervical tissue from late pregnant intact control rats on D18 and D22, the collagen concentration decreased, collagen solubility increased, and there was no significant change in total glycosaminoglycan concentration. In cervices from ovariectomized pregnant rats treated with progesterone and estrogen, collagen and glycosaminoglycan parameters resembled those of D9 and nonpregnant cervices on both D18 and D22. However, treatment of ovariectomized pregnant rats with progesterone, estrogen, and porcine relaxin (R) restored cervical collagen concentrations to those of intact controls on both D18 and D22. On D18 of pregnancy, cervical collagen solubility was partially increased by R treatment, and by D22, it was similar to that of intact D22 pregnant controls. R treatment also resulted in a significantly increased cervical concentration of HA. It is concluded that the decrease in collagen concentration, increase in collagen solubility, and increase in HA concentration resulting from R action may contribute in part to the increased extensibility of the cervix that occurs during late pregnancy in the rat.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943482     DOI: 10.1210/endo-118-2-471

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

Review 1.  Mechanics of cervical remodelling: insights from rodent models of pregnancy.

Authors:  Kyoko Yoshida; Charles Jayyosi; Nicole Lee; Mala Mahendroo; Kristin M Myers
Journal:  Interface Focus       Date:  2019-08-16       Impact factor: 3.906

2.  Relaxin has a minor role in rat mammary gland growth and differentiation during pregnancy.

Authors:  L Kass; J G Ramos; H H Ortega; G S Montes; L E Bussmann; E H Luque; M Muñoz de Toro
Journal:  Endocrine       Date:  2001-08       Impact factor: 3.633

3.  Hyaluronan and its binding proteins during cervical ripening and parturition: dynamic changes in size, distribution and temporal sequence.

Authors:  Monika Ruscheinsky; Carol De la Motte; Mala Mahendroo
Journal:  Matrix Biol       Date:  2008-03-18       Impact factor: 11.583

4.  Relaxin induces matrix-metalloproteinases-9 and -13 via RXFP1: induction of MMP-9 involves the PI3K, ERK, Akt and PKC-ζ pathways.

Authors:  Nisar Ahmad; Wei Wang; Remi Nair; Sunil Kapila
Journal:  Mol Cell Endocrinol       Date:  2012-07-24       Impact factor: 4.102

5.  Relaxin regulates hyaluronan synthesis and aquaporins in the cervix of late pregnant mice.

Authors:  Yu May Soh; Anjana Tiwari; Mala Mahendroo; Kirk P Conrad; Laura J Parry
Journal:  Endocrinology       Date:  2012-10-19       Impact factor: 4.736

6.  Modelling of Soft Connective Tissues to Investigate Female Pelvic Floor Dysfunctions.

Authors:  Aroj Bhattarai; Manfred Staat
Journal:  Comput Math Methods Med       Date:  2018-01-15       Impact factor: 2.238

7.  Immunoexpression of Relaxin and Its Receptors in Stifle Joints of Dogs with Cranial Cruciate Ligament Disease.

Authors:  Brunella Restucci; Mariafrancesca Sgadari; Gerardo Fatone; Giovanni Della Valle; Federica Aragosa; Chiara Caterino; Gianmarco Ferrara; Gert W Niebauer
Journal:  Animals (Basel)       Date:  2022-03-23       Impact factor: 2.752

8.  Retention of urine in women is alleviated by uterosacral ligament repair: implications for Fowler's syndrome.

Authors:  Peter Petros; Burghard Abendstein; Michael Swash
Journal:  Cent European J Urol       Date:  2018-10-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.